| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 23/05/2024 | 14:05 | GlobeNewswire Inc. | Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance | NASDAQ:CDMOP | Avid Bioservices Inc |
| 07/05/2024 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Participate at Upcoming Investor Conferences | NASDAQ:CDMOP | Avid Bioservices Inc |
| 24/04/2024 | 23:25 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 20/03/2024 | 12:00 | GlobeNewswire Inc. | Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q | NASDAQ:CDMOP | Avid Bioservices Inc |
| 07/03/2024 | 05:58 | GlobeNewswire Inc. | Avid Bioservices Announces Pricing of Private Placement of Convertible Notes | NASDAQ:CDMOP | Avid Bioservices Inc |
| 06/03/2024 | 22:32 | GlobeNewswire Inc. | Avid Bioservices Announces Proposed Private Placement of Convertible Notes | NASDAQ:CDMOP | Avid Bioservices Inc |
| 06/03/2024 | 22:31 | GlobeNewswire Inc. | Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 07/12/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 30/11/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 08/11/2023 | 14:05 | GlobeNewswire Inc. | Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs | NASDAQ:CDMOP | Avid Bioservices Inc |
| 17/10/2023 | 14:05 | GlobeNewswire Inc. | Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility | NASDAQ:CDMOP | Avid Bioservices Inc |
| 26/09/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference | NASDAQ:CDMOP | Avid Bioservices Inc |
| 07/09/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 31/08/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 21/06/2023 | 23:01 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CDMOP | Avid Bioservices Inc |
| 21/06/2023 | 22:47 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CDMOP | Avid Bioservices Inc |
| 21/06/2023 | 22:07 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 14/06/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 09/06/2023 | 01:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CDMOP | Avid Bioservices Inc |
| 10/05/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference | NASDAQ:CDMOP | Avid Bioservices Inc |
| 06/05/2023 | 01:36 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CDMOP | Avid Bioservices Inc |
| 04/04/2023 | 14:05 | GlobeNewswire Inc. | Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers | NASDAQ:CDMOP | Avid Bioservices Inc |
| 13/03/2023 | 21:05 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments | NASDAQ:CDMOP | Avid Bioservices Inc |
| 06/03/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 14/02/2023 | 18:44 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CDMOP | Avid Bioservices Inc |
| 09/02/2023 | 17:14 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CDMOP | Avid Bioservices Inc |
| 06/12/2022 | 22:36 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CDMOP | Avid Bioservices Inc |
| 06/12/2022 | 22:05 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments | NASDAQ:CDMOP | Avid Bioservices Inc |
| 29/11/2022 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022 | NASDAQ:CDMOP | Avid Bioservices Inc |
| 16/11/2022 | 14:05 | GlobeNewswire Inc. | Avid Bioservices Appoints Oksana Lukash as Vice President, People | NASDAQ:CDMOP | Avid Bioservices Inc |